MedPath

To study and compare the number of pimples reduced after giving Tazarotene gel and Adapalene gel over face in Acne patients

Not Applicable
Completed
Conditions
Health Condition 1: L700- Acne vulgaris
Registration Number
CTRI/2019/01/017011
Lead Sponsor
Dr Sanmitra Aiholli
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
82
Inclusion Criteria

1 Facial acne vulgaris of mild to moderate severity.

2 Patients willing to undergo treatment and come for follow up.

Exclusion Criteria

1 Facial acne vulgaris of severe type

2 Pregnant women & women who are planning to conceive.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath